Lord, Abbett & Co
AGN.PRA

Lord, Abbett & Co’s Allergan plc AGN.PRA Stock Holding History

Lord, Abbett & Co’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-27,430
Closed -$16.1M – 951
2017
Q4 		$16.1M Sell
27,430
-12,569
-31% -$8.11M 0.05% 519
2017
Q3 		$29.5M Sell
39,999
-10,660
-21% -$8.85M 0.09% 372
2017
Q2 		$44M Sell
50,659
-10,841
-18% -$9.08M 0.13% 239
2017
Q1 		$52.3M Buy
61,500
+22,891
+59% +$19M 0.16% 205
2016
Q4 		$29.4M Sell
38,609
-491
-1% -$371K 0.09% 321
2016
Q3 		$32.1M Buy
39,100
+732
+2% +$633K 0.1% 328
2016
Q2 		$32M Sell
38,368
-9,745
-20% -$8.14M 0.1% 317
2016
Q1 		$44.2M Buy
48,113
+14,215
+42% +$13.6M 0.14% 228
2015
Q4 		$34.9M Sell
33,898
-20,640
-38% -$20.7M 0.11% 306
2015
Q3 		$51.5M Buy
54,538
+1,295
+2% +$1.35M 0.16% 204
2015
Q2 		$55.5M Buy
+53,243
New +$55.7M 0.15% 210

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Lord, Abbett & Co's AGN.PRA Position: Q1 2018 in Review

Lord, Abbett & Co sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 27,430 shares — an estimated $16.1M sold.

Lord, Abbett & Co first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $55.5M in Q2 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Lord, Abbett & Co reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Lord, Abbett & Co sold 27,430 Allergan plc shares in Q1 2018, an estimated $16.1M.
  • Lord, Abbett & Co first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Lord, Abbett & Co's Allergan plc position peaked at $55.5M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Lord, Abbett & Co's 13F filing for Q1 2018, filed 15 May 2018.